Literature DB >> 18353959

Nuclear localization sequences in cytomegalovirus capsid assembly proteins (UL80 proteins) are required for virus production: inactivating NLS1, NLS2, or both affects replication to strikingly different extents.

Nang L Nguyen1, Amy N Loveland, Wade Gibson.   

Abstract

Scaffolding proteins of spherical prokaryotic and eukaryotic viruses have critical roles in capsid assembly. The primary scaffolding components of cytomegalovirus, called the assembly protein precursor (pAP, pUL80.5) and the maturational protease precursor (pPR, pUL80a), contain two nuclear localization sequences (NLS1 and NLS2), at least one of which is required in coexpression experiments to translocate the major capsid protein (MCP, pUL85) into the nucleus. In the work reported here, we have mutated NLS1 and NLS2, individually or together, in human cytomegalovirus (HCMV, strain AD169) bacmid-derived viruses to test their effects on virus replication. Consistent with results from earlier transfection/coexpression experiments, both single-mutant bacmids gave rise to infectious virus but the double mutant did not. In comparisons with the wild-type virus, both mutants showed slower cell-to-cell spread; decreased yields of infectious virus (3-fold lower for NLS1(-) and 140-fold lower for NLS2(-)); reduced efficiency of pAP, pPR, and MCP nuclear translocation (sixfold lower for NLS1(-) and eightfold lower for NLS2(-)); increased amounts of a 120-kDa MCP fragment; and reduced numbers of intranuclear capsids. All effects were more severe for the NLS2(-) mutant than the NLS1(-) mutant, and a distinguishing feature of cells infected with the NLS2(-) mutant was the accumulation of large, UL80 protein-containing structures within the nucleus. We conclude that these NLS assist in the nuclear translocation of MCP during HCMV replication and that NLS2, which is unique to the betaherpesvirus UL80 homologs, may have additional involvements during replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353959      PMCID: PMC2395177          DOI: 10.1128/JVI.02697-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Structure and polymorphism of the UL6 portal protein of herpes simplex virus type 1.

Authors:  Benes L Trus; Naiqian Cheng; William W Newcomb; Fred L Homa; Jay C Brown; Alasdair C Steven
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence.

Authors:  J Robbins; S M Dilworth; R A Laskey; C Dingwall
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

3.  The erasable Western blot.

Authors:  S H Kaufmann; C M Ewing; J H Shaper
Journal:  Anal Biochem       Date:  1987-02-15       Impact factor: 3.365

4.  A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity.

Authors:  E Zacksenhaus; R Bremner; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

5.  Structural and nonstructural proteins of strain Colburn cytomegalovirus.

Authors:  W Gibson
Journal:  Virology       Date:  1981-06       Impact factor: 3.616

6.  Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus.

Authors:  A Irmiere; W Gibson
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

7.  Human cytomegalovirus (HCMV) smallest capsid protein identified as product of short open reading frame located between HCMV UL48 and UL49.

Authors:  W Gibson; K S Clopper; W J Britt; M K Baxter
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

8.  Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952.

Authors:  K D Greis; W Gibson; G W Hart
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Herpesvirus proteinase: site-directed mutagenesis used to study maturational, release, and inactivation cleavage sites of precursor and to identify a possible catalytic site serine and histidine.

Authors:  A R Welch; L M McNally; M R Hall; W Gibson
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Assembly of the herpes simplex virus capsid: identification of soluble scaffold-portal complexes and their role in formation of portal-containing capsids.

Authors:  William W Newcomb; Darrell R Thomsen; Fred L Homa; Jay C Brown
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more
  7 in total

1.  Cytomegalovirus capsid protease: biological substrates are cleaved more efficiently by full-length enzyme (pUL80a) than by the catalytic domain (assemblin).

Authors:  Steve M Fernandes; Edward J Brignole; Kanchan Taori; Wade Gibson
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Release of the herpes simplex virus 1 protease by self cleavage is required for proper conformation of the portal vertex.

Authors:  Kui Yang; Elizabeth G Wills; Joel D Baines
Journal:  Virology       Date:  2012-04-28       Impact factor: 3.616

3.  Murine cytomegalovirus capsid assembly is dependent on US22 family gene M140 in infected macrophages.

Authors:  Laura K Hanson; Jacquelyn S Slater; Victoria J Cavanaugh; William W Newcomb; Lisa L Bolin; Christine N Nelson; Lisa D Fetters; Qiyi Tang; Jay C Brown; Gerd G Maul; Ann E Campbell
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

Review 4.  Functional annotation of human cytomegalovirus gene products: an update.

Authors:  Ellen Van Damme; Marnix Van Loock
Journal:  Front Microbiol       Date:  2014-05-19       Impact factor: 5.640

5.  Enhanced tumour cell nuclear targeting in a tumour progression model.

Authors:  Michael S Nastasie; Helmut Thissen; David A Jans; Kylie M Wagstaff
Journal:  BMC Cancer       Date:  2015-02-21       Impact factor: 4.430

6.  Human Cytomegalovirus Nuclear Capsids Associate with the Core Nuclear Egress Complex and the Viral Protein Kinase pUL97.

Authors:  Jens Milbradt; Eric Sonntag; Sabrina Wagner; Hanife Strojan; Christina Wangen; Tihana Lenac Rovis; Berislav Lisnic; Stipan Jonjic; Heinrich Sticht; William J Britt; Ursula Schlötzer-Schrehardt; Manfred Marschall
Journal:  Viruses       Date:  2018-01-13       Impact factor: 5.048

7.  Cost minimization analysis of an in-house molecular test for cytomegalovirus in relation to a commercial molecular system.

Authors:  Cássia F B Caurio; Odelta S Allende; Roger Kist; Izadora C S Vasconcellos; Francieli P Rozales; Maikel Reck-Kortmann; Daiane F Dalla Lana; Ana Paula Alegretti; Giácomo B Neto; Alessandro C Pasqualotto
Journal:  Braz J Infect Dis       Date:  2020-05-23       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.